Related references
Note: Only part of the references are listed.Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice
Eva Conde et al.
NATURE COMMUNICATIONS (2021)
IFN-alpha kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study
Frederic A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease
Peter J. Barnes
NATURE REVIEWS IMMUNOLOGY (2018)
A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma
Diego Bagnasco et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
Sustained Suppression of IL-13 by a Vaccine Attenuates Airway Inflammation and Remodeling in Mice
Yanbing Ma et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia
Roland Ventura et al.
VACCINE (2013)
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
Enrico Malito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Control of allergic reactions in mice by an active anti-murine IL-4 immunization
Helene Le Buanec et al.
VACCINE (2007)